pdf
Published
2020-07-10
Issue
Section
Formulary Evaluations
License
Copyright (c) 2020 Paul Langley, Stephen McKenna
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
Post QALY: Scientific Approaches to Real World Formulary Decision Making
INNOVATIONS in pharmacy 10th Anniversary Celebration Special ‘Call for Papers’ in the Formulary Evaluations Section of the Journal
Paul Langley
College of Pharmacy University of Minnesota
Stephen McKenna
Population Health, University of Manchester, Manchester UK
DOI: https://doi.org/10.24926/iip.v11i2.3375
Abstract
The purpose of this anniversary supplement for Innovations in Pharmacy is to consider and / or propose modern, scientific methods for determining the evidence base for the fair pricing and accessibility of pharmaceutical products and medical devices. At present, such decisions are based on the construction of imaginary value assessment models that fail to meet the standards of normal science. Such a business model has been adopted by the Institute for Clinical and Economic Review (ICER) in the US, NICE in the UK and in a number of other countries.
Article Type: Call for Papers
